Simponi (Golimumab)
Simponi is a biologic prescription medication that targets, binds with, and blocks excess TNF-alpha (tumor necrosis factor-alpha), an underlying cause of inflammation.
Indication:
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Ulcerative Colitis
Infusion Duration:
Frequency:
Loading Dose: Weeks 0 and 4
Maintenance Dose: Every 8 weeks